Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia.
Authors: Boztug K,  Rosenberg PS,  Dorda M,  Banka S,  Moulton T,  Curtin J,  Rezaei N,  Corns J,  Innis JW,  Avci Z,  Tran HC,  Pellier I,  Pierani P,  Fruge R,  Parvaneh N,  Mamishi S,  Mody R,  Darbyshire P,  Motwani J,  Murray J,  Buchanan GR,  Newman WG,  Alter BP,  Boxer LA,  Donadieu J,  Welte K,  Klein C
Journal: J Pediatr
Date: 2012 Apr
Branches: BB, CGB
PubMed ID: 22050868
PMC ID: not available
Abstract: OBJECTIVE: To delineate the phenotypic and molecular spectrum of patients with a syndromic variant of severe congenital neutropenia (SCN) due to mutations in the gene encoding glucose-6-phosphatase catalytic subunit 3 (G6PC3). STUDY DESIGN: Patients with syndromic SCN were characterized for associated malformations and referred to us for G6PC3 mutational analysis. RESULTS: In a cohort of 31 patients with syndromic SCN, we identified 16 patients with G6PC3 deficiency including 11 patients with novel biallelic mutations. We show that nonhematologic features of G6PC3 deficiency are good predictive indicators for mutations in G6PC3. Additionally, we demonstrate genetic variability in this disease and define novel features such as growth hormone deficiency, genital malformations, disrupted bone remodeling, and abnormalities of the integument. G6PC3 mutations may be associated with hydronephrosis or facial dysmorphism. The risk of transition to myelodysplastic syndrome/acute myeloid leukemia may be lower than in other genetically defined SCN subgroups. CONCLUSIONS: The phenotypic and molecular spectrum in G6PC3 deficiency is wider than previously appreciated. The risk of transition to myelodysplastic syndrome or acute myeloid leukemia may be lower in G6PC3 deficiency compared with other subgroups of SCN.